Clinical Trial Assay Development for Precision Medicine: Insights from Pharma & Diagnostics Experts
Explore the latest insights and case studies on different approaches to clinical trial assay development, validation, and deployment in trials for both oncology and chronic disease indications from both a biopharma and diagnostics perspective.
This webinar will cover several key topics related to biomarker-driven clinical trials. Attendees will learn how to maximize success in these types of trials globally, with a specific focus on the importance of China. Additionally, there will be a discussion on the regulatory challenges associated with the latest thinking on IVDR Europe.
Join this webinar to get an in-depth look at the opportunities and challenges of clinical trial assay development & validation and the critical steps involved to ensure that they are ready for stratification use within clinical trials.
What You Will Learn
Attendees will:
- Hear from both AstraZeneca and Boehringer Ingelheim on their approach to clinical trial assay development, validation and deployment in clinical trials for both oncology and chronic disease indications
- Hear from Almac on differing approaches to clinical trial assay development & validation in the lab relating to specific disease indications and intended use
- Explore how to maximize the success of biomarker driven clinical trials globally, including a focus on the importance of China
- Discuss regulatory challenges around the latest thinking on IVDR Europe
Speakers:
View Resource